Sex differences in cardiovascular disease risk in type 1 diabetes: The vascular bed paradox in women

Abigayle B Simon1, Dhruti Trivedi1, Marsha Blackburn1

  • 1Georgia Prevention Institute, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Insights

Women with type 1 diabetes (T1D) show better blood vessel function but increased aortic stiffness compared to men with T1D. This highlights the complex vascular health differences in T1D, requiring multiple assessments for cardiovascular disease risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in type 1 diabetes (T1D).
  • Women with T1D face a higher CVD risk than men with T1D.
  • Understanding sex-based differences in vascular health is crucial for T1D management.

Purpose of the Study:

  • To investigate sex-specific differences in vascular health among individuals with T1D.
  • To compare endothelial-dependent and -independent vasodilation between men and women with T1D.
  • To assess microvascular function, arterial stiffness, and skeletal muscle oxidative capacity in relation to sex.

Main Methods:

  • Flow-mediated dilation (FMD) for conduit artery endothelial function.
  • Nitroglycerin (NTG) testing for endothelial-independent vasodilation.
  • Cutaneous post-occlusive reactive hyperemia (PORH), local thermal heating (LTH), iontophoresis of acetylcholine (ACH), pulse wave velocity (PWV), pulse wave analysis (AIx75), and near-infrared spectroscopy for SMOC.

Main Results:

  • No significant differences in Hemoglobin A1c or microvascular function (PORH, LTH, ACH) between sexes.
  • Women with T1D demonstrated higher FMD (endothelial function) and AIx75 (aortic stiffness) compared to men with T1D.
  • Arterial stiffness (PWV) and skeletal muscle oxidative capacity (SMOC) were similar between groups.

Conclusions:

  • Women with T1D exhibit enhanced conduit vessel endothelial function but increased aortic stiffness versus men with T1D.
  • This paradox underscores the complexity of vascular health in T1D, necessitating comprehensive assessment.
  • Evaluating multiple vascular indices is vital for accurate CVD risk stratification in both sexes with T1D.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...